Patent ID: 7846457

Claim:
A method of temporarily elevating the eyebrow position and softening undesirable glabellar muscle activity to effect a more desirable appearance, comprising: injecting botulinum toxin (BTX) dissolved in microdroplets of injectable saline carrier to treat the septal and orbital orbicularis oculi muscles, on each side of a patient's face, wherein said botulinum toxin (BTX) comprises doses of 0.001 to 1.0 Unit equivalents of Clostridum botulinum toxin A; wherein said doses of BTX are dissolved in 0.01 to 0.05 ml microdroplets of injectable saline carrier; wherein said microdroplets of BTX solution are injected 0.5 to 1.0 millimeters below the skin surface where the muscles of facial expression responsible for eyebrow and glabellar depression insert into the skin; wherein said injected microdroplets of BTX are distributed over the muscles of facial expression responsible for eyebrow and glabellar depression including the septal and orbital orbicularis oculi muscles, and the inferior portion of the frontalis muscles where they insert into the skin at the level of the eyebrows; wherein the total number of microdroplets of botulinum toxin are adjusted to achieve the desired degree of muscle weakening.